-
Is Akums Drugs and Pharmaceuticals a Good Buy After Its Q1 FY27 Results?
- September 7, 2026
- Posted by: Lakshit Sharma
- Category: Market
No Comments
Akums Drugs and Pharmaceuticals Q1 FY27: revenue Rs 1,197 crore, PAT Rs 101 crore. Full results breakdown and whether the stock is a buy at current levels.
-
Aban Offshore vs Nifty 50: Share Price Performance Compared
- September 7, 2026
- Posted by: Neeraj Pandey
- Category: Market
A data-led look at how Aban Offshore share price has performed against the Nifty 50 across multiple time frames.
-
Aarvi Encon vs Nifty 50: Share Price Performance Compared
- September 7, 2026
- Posted by: Neeraj Pandey
- Category: Market
A data-led look at how Aarvi Encon share price has performed against the Nifty 50 across multiple time frames.
-
Advent Hotels International vs Nifty 50: Returns Compared
- September 7, 2026
- Posted by: Neeraj Pandey
- Category: Market
A data-led look at how Advent Hotels International share price has performed against the Nifty 50 across multiple time frames.
-
Acutaas Chemicals vs Nifty 50: Share Price Performance Compared
- September 7, 2026
- Posted by: Lakshit Sharma
- Category: Market
A data-led look at how Acutaas Chemicals share price has performed against the Nifty 50 across multiple time frames.
-
Advait Energy Transitions vs Nifty 50: Returns Compared
- September 7, 2026
- Posted by: Neeraj Pandey
- Category: Market
A data-led look at how Advait Energy Transitions share price has performed against the Nifty 50 across multiple time frames.
-
Ador Welding vs Nifty 50: Share Price Performance Compared
- September 7, 2026
- Posted by: Neeraj Pandey
- Category: Market
A data-led look at how Ador Welding share price has performed against the Nifty 50 across multiple time frames.
-
Is Alivus Life Sciences a Good Buy After Its Q1 FY27 Results?
- September 7, 2026
- Posted by: Lakshit Sharma
- Category: Market
Alivus Life Sciences Q1 FY27: revenue Rs 640 crore, PAT Rs 160 crore. Full results breakdown and whether the stock is a buy at current levels.
-
Aeroflex Neu vs Nifty 50: Share Price Performance Compared
- September 7, 2026
- Posted by: Lakshit Sharma
- Category: Market
A data-led look at how Aeroflex Neu share price has performed against the Nifty 50 across multiple time frames.
-
Is Ajmera Realty and Infra India a Good Buy After Its Q1 FY27 Results?
- September 7, 2026
- Posted by: Lakshit Sharma
- Category: Market
Ajmera Realty and Infra India Q1 FY27: revenue Rs 320 crore, PAT Rs 45 crore. Full results breakdown and whether the stock is a buy at current levels.